Ki67 as a predictor of poor prognosis in patients with triplenegative breast cancer

By  

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 149-152

Spandidos Publications

Access to resources Recommend Favorite

Bcl-2 as a predictor of chemosensitivity and prognosis in primary epithelial ovarian cancer - association with clinical outcome

By Mano Y.   Kikuchi Y.   Yamamoto K.   Kita T.   Hirata J.   Tode T.   Ishii K.   Nagata I.  

European Journal of Cancer, Vol. 35, Iss. 8, 1999-08 ,pp. : 1214-1219

Elsevier

Access to resources Recommend Favorite

The clinical significance of axillary sentinel lymph node biopsy in different clinical stages breast cancer patients after neoadjuvant chemotherapy

By Xu Juan   Wu Xinhong   Feng Yaojun   Yuan Feng   Fan Wei  

The Chinese-German Journal of Clinical Oncology, Vol. 12, Iss. 11, 2013-11 ,pp. : 521-523

Springer Publishing Company

Access to resources Recommend Favorite

Studies of the Potential Utility of Ki67 as a Predictive Molecular Marker of Clinical Response in Primary Breast Cancer

By Assersohn L.  

Breast Cancer Research and Treatment, Vol. 82, Iss. 2, 2003-01 ,pp. : 113-123

Springer Publishing Company

Access to resources Recommend Favorite

Clinical significance of Smac and survivin expression in breast cancer patients treated with anthracyclinebased neoadjuvant chemotherapy

By              

Molecular Medicine Reports, Vol. 9, Iss. 2, 2014-01 ,pp. : 614-620

Spandidos Publications

Access to resources Recommend Favorite